(4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide CAS: 1335210-35-9
![BK0WD8 | 1335210-35-9 | (4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide](https://qncdn.chemcd.cn/alchemypharm/1335210-35-9.png "BK0WD8 | 1335210-35-9 | (4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide")
| Product Parameters | |
|---|---|
| Catalog No. | BK0WD8 |
| CAS.RN | 1335210-35-9 |
| Molecular Formula | C21H21F2N3O5 |
| Molecular Weight | 433.41 g/mol |
| Purity | NLT 98% |
Product Overview
(4R,12aS)-N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-methoxy-4-methyl-6,8-dioxo-2H-pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide is a structurally complex pharmaceutical intermediate widely used in the synthesis of novel antitumor drugs and targeted therapies. This compound exhibits high stereoselectivity and functional group compatibility, making it suitable for the development and optimization of various organic synthetic routes. It can meet the needs of multiple stages from laboratory research to industrial production, and is one of the key starting materials in current medicinal chemistry research.
Applications
- Antitumor drug synthesis
- Targeted therapy drug intermediates
- Drug molecular skeleton construction
- Organic synthesis route development
- Customized pharmaceutical intermediate supply
Quality & Supply Capability
English Name: (4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide Properties: This product is a white to off-white solid with a stable heterocyclic structure and multiple oxygen heteroatom functional groups. It possesses good reactivity and thermal stability, making it suitable for various organic synthesis reaction systems. Storage Recommendations: Store in a sealed, light-proof, and dry place, subject to the specific requirements of the COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide a one-stop service from sample supply, small-scale preparation, pilot-scale amplification to customized batch production. We can flexibly adjust the supply plan according to customer requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documentation. Simultaneously, we have a professional technical team to provide customers with full-process technical support from laboratory R&D to scale-up production, helping customers efficiently advance process development, route optimization, and project transformation.
Why Choose Bioncan
Focused on pharmaceutical intermediates, possessing extensive synthesis experience and technological expertise. Full-scale supply capabilities, covering needs from laboratory to commercial production. Provides complete quality control documentation to ensure product quality compliance and controllability. Supports customized needs, enabling process adjustments and product optimization based on specific customer requirements. Supports scale-up production services, providing technical support and solutions from R&D to mass production.
Intermediates of Dolutegravir
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 1335210-35-9, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.
